Heart Transplantation Complicated by COVID-19 Infection

Ann Thorac Surg. 2022 Apr;113(4):e267-e269. doi: 10.1016/j.athoracsur.2021.07.003. Epub 2021 Jul 17.

Abstract

The influence of Coronavirus-2019 (COVID-19) on heart transplantation is considerable. Reports of COVID-19 infection in recently transplanted patients are scarce. We present a 60-year-old male patient with COVID-19 infection, diagnosed 6 days after transplantation. His clinical course revealed 2 phases. Initially, there were mild respiratory symptoms for which he was treated with remdesivir and noninvasive respiratory support. In a second phase with clinical deterioration on postoperative day 22, further respiratory decline led to the administration of convalescent plasma, with satisfactory response and further improvement of his condition.

Publication types

  • Case Reports

MeSH terms

  • COVID-19 Serotherapy
  • COVID-19* / therapy
  • Heart Transplantation*
  • Humans
  • Immunization, Passive
  • Male
  • Middle Aged
  • SARS-CoV-2